Start free

PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
BlueCross BlueShield of South CarolinaCommercial · Prior Auth · Pharmacy · SC · Pharmacy, Endocrinology, Internal Medicine +3 moreHigh impact

Commercial GLP-1 Coverage Updates for Expanded FDA-Approved Indications

Act
by Aug 1, 2026
Effective date
Aug 1, 2026
Identified
Sep 19, 2026

Summary

BlueCross BlueShield of South Carolina expanded GLP-1 medication coverage for new FDA-approved indications effective August 1, 2026. Wegovy (semaglutide) is now eligible for coverage when prescribed for cardiovascular event risk reduction or metabolic liver disease, while Zepbound (tirzepatide) for obstructive sleep apnea will not be covered under plans excluding weight-loss medications. All GLP-1 prescriptions now require verification of member benefits and prior authorization before dispensing.

Get alerts when payers change rules like this one

We check BlueCross BlueShield of South Carolina and other payers every day and email you when a change matches your specialty and state.

Get BlueCross BlueShield of South Carolina alertsPolicy Monitoring is free. No card required.

What to do

by Aug 1, 2026 · 7 steps
01Billing and clinical teams must implement the following.
02Update prior authorization protocols in billing software to flag all Wegovy (semaglutide) and Zepbound (tirzepatide) prescriptions for GLP-1 coverage verification based on indicated diagnosis.
03Train providers and front desk staff that Wegovy prescriptions for MACE risk reduction or MASH require prior authorization approval before billing.
04Configure system to reject or flag Zepbound claims for OSA on plans that exclude weight-loss GLP-1 medications.
05Establish workflow requiring verification of member-specific formulary status and benefit design BEFORE prescribing any GLP-1 therapy.
06Update encounter forms and EMR templates to document the specific FDA-approved indication being treated.
07Providers must confirm prior authorization requirements at time of prescribing.
If missed: Failure to obtain required prior authorization will result in claim denials, and prior auth approval does not guarantee payment if the member's plan excludes the medication or indication.

Original notice

Commercial GLP-1 Coverage Updates for Expanded FDA-Approved Indications
southcarolinablues.com · Always check the source before changing claims.
View original ↗

Related policy hubs

BlueCross BlueShield of South Carolina policiesSC policy changesPharmacyEndocrinologyInternal MedicineCardiologyGastroenterologySleep Medicine

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Policy MonitoringPayer policy, prior auth and coding changes, filtered to your saved searchesOIG ScreeningStaff and vendors screened every month against OIG LEIE, SAM.gov and state Medicaid listsPrior Auth LookupKnow if a service needs prior authorization before you schedule itCredentialing TrackerLicenses, CAQH, Medicare revalidation and payer enrollments, with reminders before anything lapsesCompliance CenterKeep your HIPAA program documented and ready to show
Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account